For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250328:nRSb7600Ca&default-theme=true
RNS Number : 7600C Glanbia PLC 28 March 2025
Notice of Annual General Meeting 2025 and Proxy voting Form
28 March 2025
Glanbia plc ("Glanbia" or the "Company"), the 'Better Nutrition company',
announces that the Notice of the 2025 Annual General Meeting (the "Notice")
and the Proxy Voting Form for the 2025 Annual General Meeting (the "Proxy")
are available from today on the Company's website, and may be viewed and
downloaded online at: www.glanbia.com/agm (http://www.glanbia.com/agm) . The
Notice sets out details of the proposed business to be considered at the
Annual General Meeting, including the proposal to transfer the Company's
listing category of ordinary shares on the London Stock Exchange from the
Equity Shares (Commercial Companies) category to the Equity Shares
(International Commercial Companies Secondary Listing) category.
The Notice and the Proxy have been submitted to Euronext Dublin and the UK
National Storage Mechanism and will shortly be available for inspection at:-
https://direct.euronext.com/#/oamfiling
(https://direct.euronext.com/#/oamfiling)
and at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)
The Notice and related documents were posted today (28 March 2025) to
shareholders who have elected to receive them by post and will also be
available from the Group Secretary and Head of Investor Relations at the
Company's registered office at Glanbia House, Kilkenny, R95 E866.
Contact details
Investors
Liam Hennigan, Group Secretary and Head of Investor Relations: +353 86 046
8375
Media
Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOABUGDXLGDDGUI